Immuron Stock Forecast
NASDAQ: IMRNHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
IMRN analyst consensus
Consensus
none
Avg. price target
$3.89+260.19%
Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.
What analysts say
The average 12-month price target is $3.89, with a high estimate of $3.89 and a low estimate of $3.89. The average target implies upside of 260.2% from the current price of $1.08. The spread between the highest and lowest targets is 0.0%, a relatively narrow range.
Price targets and ratings are the opinions of third-party analysts, not MetaCap. They are frequently revised and have a mixed track record, so treat them as one input among many for IMRN.
Summary generated from market data by MetaCap's automated system. Methodology
Price target scenarios
| Target | Price | vs. current |
|---|---|---|
| Low target | $3.89 | +260.19% |
| Average target | $3.89 | +260.19% |
| High target | $3.89 | +260.19% |